Pickup

News

Apr.02, 2025 Release
Exclusive Licensing Agreement with Link Healthcare, a Clinigen Company for Cefiderocol in Australia and New Zealand
Apr.01, 2025 Notice
SHIONOGI Group Code of Conduct has been issued
Apr.01, 2025 Release
Shionogi Initiates New Drug Application Submission for Ensitrelvir for Post-Exposure Prophylaxis with the U.S. Food and Drug Administration
Mar.27, 2025 Release
Shionogi Submits Supplemental New Drug Application for Ensitrelvir in Japan for the Post-Exposure Prophylaxis of COVID-19.
Mar.24, 2025 Release
Shionogi Announces Appointment of Corporate officers, the Establishment of new Organization and Personnel Reassignment (Effective April 1, Jun 18, and July 1, 2025)
News
News List

SHIONOGI Journal

At SHIONOGI, we have passionate colleagues who embody the spirit that has been passed down for over 140 years.
We are excited to share our story of working for patients around the world, society, and our irreplaceable planet.
SHIONOGI Journal

Innovation

Shionogi's Innovation always comes from the passion to provide new value which meet the needs of society and customers, in the healthcare field.
Innovation

Pickup

Sustainability

Shionogi's susutainability programs which toward to become a company that will be needed by stakeholders now and in the future.
Sustainability

Pickup

Learn about SHIONOGI

About Shionogi

Investors

Investor Information

Careers